Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
| 1. Executive Summary |
| 2. Global Cardiac Markers Market Introduction |
| 2.1. Global Cardiac Markers Market – Taxonomy |
| 2.2. Global Cardiac Markers Market –Definitions |
| 2.2.1. By Test Type |
| 2.2.2. By Type of Testing |
| 2.2.3. By Region |
| 3. Global Cardiac Markers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Cardiac Markers Market Dynamic Factors - Impact Analysis |
| 3.6. Global Cardiac Markers Market – Competition Landscape |
| 4. Global Cardiac Markers Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 |
| 4.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Cardiac Markers Market, By Test Type, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 5.1. NT-proBNP Test |
| 5.1.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Troponin I & T |
| 5.2.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. GDF-15 |
| 5.3.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. hsCRP |
| 5.4.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Cardiac Markers Market, By Type of Testing, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 6.1. Laboratory Testing |
| 6.1.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Point of Care Testing |
| 6.2.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Cardiac Markers Market Forecast, By Region, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Region, 2022 - 2028 |
| 8. North America Cardiac Markers Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 8.1. Test Type Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. NT-proBNP Test |
| 8.1.2. Troponin I & T |
| 8.1.3. GDF-15 |
| 8.1.4. CK-MB |
| 8.1.5. hsCRP |
| 8.1.6. Others |
| 8.2. Type of Testing Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.2.1. Laboratory Testing |
| 8.2.2. Point of Care Testing |
| 8.3. Country Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
| 8.5. North America Cardiac Markers Market Dynamics – Trends |
| 9. Europe Cardiac Markers Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 9.1. Test Type Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. NT-proBNP Test |
| 9.1.2. Troponin I & T |
| 9.1.3. GDF-15 |
| 9.1.4. CK-MB |
| 9.1.5. hsCRP |
| 9.1.6. Others |
| 9.2. Type of Testing Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Laboratory Testing |
| 9.2.2. Point of Care Testing |
| 9.3. Country Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Russia |
| 9.3.7. Rest of Europe |
| 9.4. Europe Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
| 9.5. Europe Cardiac Markers Market Dynamics – Trends |
| 10. Asia-Pacific Cardiac Markers Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 10.1. Test Type Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. NT-proBNP Test |
| 10.1.2. Troponin I & T |
| 10.1.3. GDF-15 |
| 10.1.4. CK-MB |
| 10.1.5. hsCRP |
| 10.1.6. Others |
| 10.2. Type of Testing Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Laboratory Testing |
| 10.2.2. Point of Care Testing |
| 10.3. Country Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Japan |
| 10.3.2. China |
| 10.3.3. India |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
| 10.5. Asia-Pacific Cardiac Markers Market Dynamics – Trends |
| 11. Latin America Cardiac Markers Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 11.1. Test Type Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. NT-proBNP Test |
| 11.1.2. Troponin I & T |
| 11.1.3. GDF-15 |
| 11.1.4. CK-MB |
| 11.1.5. hsCRP |
| 11.1.6. Others |
| 11.2. Type of Testing Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Laboratory Testing |
| 11.2.2. Point of Care Testing |
| 11.3. Country Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
| 11.5. Latin America Cardiac Markers Market Dynamics – Trends |
| 12. Middle East and Africa Cardiac Markers Market Analysis, 2017 - 2021and Forecast, 2022 - 2028 (Revenue, US$ Mn) |
| 12.1. Test Type Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. NT-proBNP Test |
| 12.1.2. Troponin I & T |
| 12.1.3. GDF-15 |
| 12.1.4. CK-MB |
| 12.1.5. hsCRP |
| 12.1.6. Others |
| 12.2. Type of Testing Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Laboratory Testing |
| 12.2.2. Point of Care Testing |
| 12.3. Country Analysis 2017 - 2021and Forecast 2022 - 2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA Cardiac Markers Market - Opportunity Analysis Index, By Test Type, Type of Testing, and Country, 2022 - 2028 |
| 12.5. MEA Cardiac Markers Market Dynamics – Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, Test Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. F. Hoffman-LA Roche |
| 13.2.2. Abbott Laboratories |
| 13.2.3. Siemens |
| 13.2.4. Danaher Corporation |
| 13.2.5. Biomerieux |
| 13.2.6. Ortho Clinical Diagnostics |
| 13.2.7. Randox Laboratories |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
Download Free Sample Report
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Content Updated Date: Jan 2025
Key Market Players